Clinical Trial Update: Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing two oral formulations of diphenhydramine hydrochloride, assessing pharmacokinetic equivalence in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Congestion

Drugs mentioned

• Diphenhydramine hydrochloride (Diphenhydramine hydrochloride)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Nasal Congestion | Phase 1 | Status: COMPLETED